At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
P20 Extending Sleep to Reverse Metabolic Syndrome in Middle-Aged Adults: Acceptability and Feasibility of a Sleep Intervention
In Brief
A clinical study evaluating Sleep Intervention and Week 2 Intervention for Metabolic Syndrome. Completed, enrolled 44 participants across 1 site.
Detailed Summary
This pilot study will test the acceptability and feasibility of a sleep extension intervention in community-dwelling, short-sleeping, racially/ethnically diverse middle-aged adults with MetS. Baseline sleep habits will be assessed and used to guide individualized strategies to extend sleep. A 1-group pretest-posttest study design will test the efficacy of this 18-week study (2 weeks of baseline data collection, 1 week of study intervention planning, 12 weeks of sleep intervention delivery, final follow up 3 weeks after last day of the 12-week intervention) on sleep duration, MetS risk behaviors (reduced physical activity, increased sedentary behavior, poor diet quality), symptoms associated with MetS risk behaviors (poor affective well-being, fatigue), and self-regulation. Socio-ecological barriers and facilitators to the intervention will be identified using a quantitative and qualitative approac
Study Details
Timeline
Interventions
* Sleep Diaries (Daily) * Fitbit 24/7 * Phone/ video conference calls (weekly with study team) * Epworth Sleepiness Scale (weekly) * PROMIS fatigue scale-evening (weekly)
* Sleep Diaries (Daily) * Phone Calls (weekly with study team) * Wrist Accelerometry and fitbit 24/7 for 14 days * SAFTEE Questionnaire * ASA24 * Behavioral risk factor surveillance system (smoking and alcohol use questions) * Psychological well-being (SF36) * Index of Self Regulation * PROMIS fatigue scale-morning (weekly) * PROMIS fatigue scale-evening (weekly) * Epworth Sleepiness Scale (weekly)